Nephros (NEPH) EPS (Weighted Average and Diluted) (2010 - 2026)
Nephros (NEPH) recorded quarterly EPS (Weighted Average and Diluted) of $0.01 in Q1 2026, little changed quarter-over-quarter from $0.01 in Q4 2025, and down 80.0% on a YoY basis from $0.05 in Q1 2025.
Nephros (NEPH) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Nephros' EPS (Weighted Average and Diluted) history runs 10 years deep, the most recent figure standing at $0.01 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 80.0% year-over-year to $0.01; the TTM figure through Mar 2026 stood at $0.07 (down 12.5% YoY), while the FY2025 annual figure was $0.11, up 1000.0% from the prior year.
- EPS (Weighted Average and Diluted) was $0.01 for Q1 2026 at Nephros, roughly flat from $0.01 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.21 in Q4 2022 to a low of -$0.31 in Q3 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.01 across 5 years, with a median of -$0.01 in 2023.
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) tumbled 128.57% in 2023, then surged 350.0% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.21 in 2022, then sank by 128.57% to -$0.06 in 2023, then soared by 166.67% to $0.04 in 2024, then tumbled by 75.0% to $0.01 in 2025, then grew by 0.0% to $0.01 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.01 (Q1 2026), $0.01 (Q4 2025), and $0.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.02 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | 0.21 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | -0.12 |
| Mar 31, 2016 | -0.02 |
| Sep 30, 2015 | -0.02 |
| Jun 30, 2015 | -0.06 |
| Mar 31, 2015 | -0.02 |